Sarcoidosis vasculitis and diffuse lung diseases
Published: 01-12-2009
Editorial
Antioxidant therapy for idiopathic pulmonary fibrosis. A promising therapeutic prospect
Abstract 59 | PDF (Italian) Downloads 60Page 83-84
Original Articles: Clinical Research
Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Registry
Abstract 85 | PDF (Italian) Downloads 59Page 85-91
Fatigue in sarcoidosis: American versus Dutch patients
Abstract 82 | PDF (Italian) Downloads 55Page 92-97
Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study
Abstract 58 | PDF (Italian) Downloads 56Page 98-109
Inhaled iloprost for sarcoidosis associated pulmonary hypertension
Abstract 106 | PDF (Italian) Downloads 100Page 110-120
Steroid-Sparing effects of pentoxifylline in pulmonary sarcoidosis
Abstract 77 | PDF (Italian) Downloads 67Page 121-131
Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia
Abstract 97 | PDF (Italian) Downloads 65Page 132-138
Original Articles: Laboratory Research
Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis
Abstract 70 | PDF (Italian) Downloads 53Page 139-146
N-acetylcysteine inhibits TNF-a, sTNFR, and TGF-b1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro
Abstract 69 | PDF (Italian) Downloads 218Page 147-154
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis
Abstract 140 | PDF (Italian) Downloads 73Page 155-161
Case Reports
Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis
Abstract 143 | PDF (Italian) Downloads 59Page 162-166
Letter to Editor
Lupus pernio: a tale of four characters in search of a malady
Abstract 187 | PDF (Italian) Downloads 55Page 167-171